Ge, F.; Wang, Y.; Sharma, A.; Yang, Y.; Liu, H.; Essler, M.; Jaehde, U.; Schmidt-Wolf, I.G.H.
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma. Int. J. Mol. Sci. 2023, 24, 12476.
https://doi.org/10.3390/ijms241512476
AMA Style
Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH.
Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma. International Journal of Molecular Sciences. 2023; 24(15):12476.
https://doi.org/10.3390/ijms241512476
Chicago/Turabian Style
Ge, Fangfang, Yulu Wang, Amit Sharma, Yu Yang, Hongde Liu, Markus Essler, Ulrich Jaehde, and Ingo G. H. Schmidt-Wolf.
2023. "Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma" International Journal of Molecular Sciences 24, no. 15: 12476.
https://doi.org/10.3390/ijms241512476
APA Style
Ge, F., Wang, Y., Sharma, A., Yang, Y., Liu, H., Essler, M., Jaehde, U., & Schmidt-Wolf, I. G. H.
(2023). Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma. International Journal of Molecular Sciences, 24(15), 12476.
https://doi.org/10.3390/ijms241512476
